Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:123

Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017


Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $2,000.00
Meta Description No
Publisher GlobalData
Date of Report Dec 4, 2011
Quick Overview
Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, “Uveitis Therapeutics - Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global Uveitis Therapeutics market. The report identifies the key trends shaping and driving the global Uveitis Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Uveitis Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Uveitis Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Uveitis Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.
- Analysis of the current and future competition in the seven key countries Uveitis Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Uveitis Therapeutics therapeutics market.
- Analysis of key recent licensing and partnership agreements in Uveitis Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Uveitis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Uveitis Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Uveitis Therapeutics market landscape? – Identify, understand and capitalize.
Table of Contents
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Uveitis Therapeutics: Introduction 6
2.1 Overview 6
2.2 Etiology and Pathophysiology 7
2.3 Epidemiology 8
2.4 Symptoms 8
2.5 Diagnosis 8
2.5.1 Visual Acuity and External Examination: 8
2.5.2 Slit-lamp Examination: 8
2.5.3 Tonometry 8
2.5.4 Supplemental Examination: 9
2.6 Treatment and Management Pattern 9
2.7 GlobalData Pipeline Report Guidance 10
3 Uveitis Therapeutics: Market Characterization 11
3.1 Overview 11
3.2 Uveitis Therapeutics Market Size 11
3.3 Uveitis Therapeutics Market Size (2005-2010) – Global 11
3.4 Uveitis Therapeutics Market Forecast (2010-2017) – Global 12
3.5 Uveitis Therapeutics Market Size (2005-2010) –US 13
3.6 Uveitis Therapeutics Market Forecast (2010-2017) – US 14
3.7 Uveitis Therapeutics Market Size (2005-2010) – France 15
3.8 Uveitis Therapeutics Market Forecast (2010-2017) – France 16
3.9 Uveitis Therapeutics Market Size (2005-2010) – Germany 17
3.10 Uveitis Therapeutics Market Forecast (2010-2017) – Germany 18
3.11 Uveitis Therapeutics Market Size (2005-2010) – Italy 19
3.12 Uveitis Therapeutics Market Forecast (2010-2017) – Italy 20
3.13 Uveitis Therapeutics Market Size (2005-2010) – Spain 21
3.14 Uveitis Therapeutics Market Forecast (2010-2017) – Spain 22
3.15 Uveitis Therapeutics Market Size (2005-2010) – UK 23
3.16 Uveitis Therapeutics Market Forecast (2010-2017) – UK 24
3.17 Uveitis Therapeutics Market Size (2005-2010) – Japan 25
3.18 Uveitis Therapeutics Market Forecast (2010-2017) – Japan 26
3.19 Drivers and Barriers 27
3.19.1 Drivers for the Uveitis Therapeutics Market 27
3.19.2 Barriers for the Uveitis Therapeutics Market 27
3.20 Opportunity and Unmet needs 28
3.21 Key Takeaway 29
4 Uveitis Therapeutics Market – Competitive Assessment 30
4.1 Overview 30
4.2 Strategic Competitor Assessment 30
4.3 Product Profile for the Major Marketed Products in Uveitis Therapeutics Market 31
4.3.1 Overview 31
4.3.2 Corticosteroids 31
4.3.3 Immunosuppressants 31
4.4 Key Takeaway 31
5 Uveitis Therapeutics: Pipeline Assessment 32
5.1 Overview 32
5.2 Strategic Pipeline Assessment 32
5.3 Pipeline by Phases of Development 32
5.3.1 Uveitis Therapeutics – Regulatory Filed Products 32
5.3.2 Uveitis Therapeutics-Phase III Pipeline 33
5.3.3 Uveitis Therapeutics-Phase II Pipeline 33
5.3.4 Uveitis Therapeutics-Phase I Pipeline 33
5.3.5 Uveitis Therapeutics-Pre-Clinical Pipeline 33
5.4 Uveitis Therapeutics Market– Clinical Pipeline by Mechanism of Action. 34
5.5 Technology Trends Analytic Framework 35
5.6 Promising Drugs Under Clinical Development 36
5.7 Profile for Promising Drugs 37
5.7.1 Luveniq 37
5.7.2 AIN457 38
5.7.3 Humira 39
5.8 Key Takeaway 39
6 Uveitis Therapeutics:Clinical Trials Mapping 40
6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 40
6.2 Clinical Trials by Phase 41
6.3 Clinical Trials by Trial Status 42
6.4 Prominent Sponsors 43
6.5 Top Ten Companies Participating in Therapeutics Clinical Trials 44
7 Uveitis Therapeutics:Strategic Assessment 45
7.1 Key Events Impacting the Future Market 45
7.2 Future Market Competition Scenario 45
8 Uveitis:Future Players 47
8.1 Introduction 47
8.2 Company Profiles 47
8.2.1 Lux Biosciences 47
8.2.2 Novartis 48
8.2.3 Abbott Laboratories 51
8.2.4 Allergan 53
8.3 Other Companies in Uveitis Therapeutics Market 56
9 Uveitis Therapeutics: Liscensing and Partnership Deals 57
10 Appendix 58
10.1 Market Definitions 58
10.2 Abbreviations 58
10.3 Research Methodology 58
10.3.1 Coverage 59
10.3.2 Secondary Research 59
10.3.3 Forecasting 59
10.3.4 Primary Research 62
10.3.5 Expert Panel Validation 62
10.4 Contact Us 62
10.5 Disclaimer 62
10.6 Bibliography 63




...